The role of cyclic nucleotides and calcium in the relaxation produced by amrinone in rat aorta

General Pharmacology: The Vascular System

Volumn 34, Issue 4, 2000, Pages 245-253

  Van der Zypp, Andrea ^a   Rechtman, Mary ^b   Majewski, Henryk ^a  

^a RMIT UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Amrinone; Calcium; cAMP; cGMP; IP3

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 8 BROMO CYCLIC GMP; AMRINONE; CALCIUM; CALCIUM CHANNEL; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC NUCLEOTIDE; INOSITOL 1,4,5 TRISPHOSPHATE; ISOBUTYLMETHYLXANTHINE; MILRINONE; PHENYLEPHRINE; PHOSPHOLIPASE C; POTASSIUM CHLORIDE; PROTEIN G; SEROTONIN; THAPSIGARGIN;

ANIMAL TISSUE; AORTA; AORTA CONSTRICTION; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR CALCIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASODILATATION;

AMRINONE; ANIMALS; AORTA; BIOLOGICAL TRANSPORT; BRAIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM RADIOISOTOPES; DRUG INTERACTIONS; INOSITOL PHOSPHATES; MALE; MICROSOMES; NUCLEOTIDES, CYCLIC; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TRITIUM; VASODILATION;

EID: 0034458815     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(00)00071-9     Document Type: Article

References (48)

1. 2+ in chemically skinned aortic strips from spontaneously hypertensive (SHR) and normotensive (WKY) rats
2. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
3. Capacitative calcium entry
4. Mechanisms of action of transmitters and other substances on smooth muscle
5. cAMP analog antagonists of cAMP action
6. Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates
7. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels
8. 2+ mobilisation in canine cultured aorta smooth muscle cells
9. Calcium entry blockers and receptor-response coupling
10. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase - Basic and potential clinical applications
11. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterases
12. Diastereoisomers of adenosine 3′,5′-monothionophosphate (cAMP[s]) antagonize the activation of cGMP-dependent protein kinase
13. Differences between vasorelaxant responses of the canine and human mesenteric arteries and veins to amrinone
14. 2+-independent vasorelaxation induced by cardiotonic phosphodiesterase inhibitors
15. Pharmacological nature of TP receptor mediated contraction in human intrapulmonary artery
16. In vitro vascular relaxation by new inotropic agents: Relationship to phosphodiesterase inhibition and cyclic nucleotides
17. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta
18. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors
19. The effect of phenylephrine on inositol 1,4,5-trisphosphate levels in vascular smooth muscle measured using a protein binding assay system
20. Comparative vasoactive effects of amrinone on systemic and pulmonary arteries in rabbits
21. Comparison of the effects of milrinone and OPC 3911 with those of isoprenaline, forskolin and dibutyryl-cAMP in rat aorta
22. Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: Smooth muscle tone, platelet aggregation and cAMP levels
23. 2+ uptake and cAMP in smooth muscle
24. 2+ pathways in smooth muscle plasmalemma
25. Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast
26. + channel by cyclic AMP in cultured porcine coronary artery smooth muscle cells
27. Endothelium-dependent relaxation of rat thoracic aorta by amrinone-induced nitric oxide release
28. Rp-8-Br-guanosine-3′,5′-cyclic monophosphorothioate inhibits relaxation elicited by nitroglycerin in rabbit aorta
29. Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinase
30. + channels
31. 2+ release from intracellular membrane systems
32. Pharmacology of calcium release from sarcoplasmic reticulum
33. Tissues and species specificity of cardiac cAMP-phosphodiesterase inhibitors
34. Rapid stimulation of Ins (1,4,5)P3 production in rat aorta by NE: Correlation with contractile state
35. Cyclic nucleotide phosphodiesterases and vascular smooth muscle
36. Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle
37. Effects of norepinephrine on contraction and hydrolysis of phosphatidylinositols in rat aorta
38. A mechanistic and kinetic analysis of the interactions of the diasereoisomers of adenosine 3′, 5′ (cyclic) phosphorothioate
39. (2+)-release from rat brain microsomes
40. m) cyclic adenosine monophosphate phosphodiesterase
41. Structure, function, and regulation of adrenergic receptors
42. Inotropic agents: New positive inotropic agents and their mechanism of action
43. 2+, protein kinase C and myosin light chain phosphatase
44. Effect of milrinone on contractility and 45Ca movements in the isolated rabbit aorta
45. Changes of intracellular calcium concentrations by phenylephrine in renal arterial smooth muscle cells
46. Inositol phosphate formation and contractile response linked to alpha 1-adrenoceptor in tail artery and aorta from spontaneously hypertensive and Wistar-Kyoto rats
47. Pharmacological investigation of signaling mechanisms contributing to phasic and tonic components of the contractile response of rat arteries to noradrenaline
48. Structure and function of inositol 1,4,5-trisphosphate receptor